KEGG   PATHWAY: dle05216
Entry
dle05216                    Pathway                                
Name
Thyroid cancer - Delphinapterus leucas (beluga whale)
Description
Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.
Class
Human Diseases; Cancer: specific types
Pathway map
dle05216  Thyroid cancer
dle05216

Disease
H00032  Thyroid cancer
Organism
Delphinapterus leucas (beluga whale) [GN:dle]
Gene
111163022  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
111163990  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 [KO:K05126] [EC:2.7.10.1]
111164391  MYC; myc proto-oncogene protein [KO:K04377]
111165393  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
111165994  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
111167102  NTRK1; high affinity nerve growth factor receptor [KO:K03176] [EC:2.7.10.1]
111167157  TPM3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
111167629  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
111167640  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
111168952  [KO:K08530]
111169246  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
111169438  CTNNB1; catenin beta-1 [KO:K02105]
111169882  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
111170340  HRAS; GTPase HRas isoform X1 [KO:K02833]
111170922  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
111171490  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
111172300  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
111174776  [KO:K09290]
111176851  KRAS; GTPase KRas [KO:K07827]
111177070  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
111177653  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
111177745  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
111178438  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
111178670  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
111178690  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
111178743  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
111179595  CDH1; cadherin-1 [KO:K05689]
111179996  NRAS; GTPase NRas [KO:K07828]
111180640  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
111182181  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
111182442  TCF7; transcription factor 7 isoform X1 [KO:K02620]
111183144  TFG; protein TFG isoform X1 [KO:K09292]
111183632  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
111183968  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
111184669  TPR; nucleoprotein TPR isoform X1 [KO:K09291]
111185272  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
111185755  TP53; cellular tumor antigen p53 [KO:K04451]
111187442  PAX8; paired box protein Pax-8 [KO:K09293]
111188028  [KO:K09288]
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Related
pathway
dle03320  PPAR signaling pathway
dle04010  MAPK signaling pathway
dle04115  p53 signaling pathway
dle04310  Wnt signaling pathway
dle04520  Adherens junction
KO pathway
ko05216   

DBGET integrated database retrieval system